Transcranial Ultrasound in Clinical SONothrombolysis
Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo controlled, parallel group dose escalation trial to evaluate
the safety, tolerability, and activity of four sequential dose tiers of MRX-801 and
ultrasound as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in
subjects with acute ischemic stroke.